American International Group, Inc. Innoviva, Inc. Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$14.56 - $16.78 $13,438 - $15,487
-923 Reduced 2.86%
31,373 $478,000
Q4 2023

Feb 13, 2024
SELL
$12.32 - $16.27 $3,782 - $4,994
-307 Reduced 0.94%
32,296 $518,000
Q3 2023

Nov 13, 2023
SELL
$12.37 - $13.89 $6,568 - $7,375
-531 Reduced 1.6%
32,603 $423,000
Q2 2023

Aug 04, 2023
SELL
$11.39 - $13.72 $15,706 - $18,919
-1,379 Reduced 4.0%
33,134 $421,000
Q1 2023

May 12, 2023
BUY
$10.73 - $13.6 $1,684 - $2,135
157 Added 0.46%
34,513 $388,000
Q4 2022

Feb 10, 2023
SELL
$11.8 - $13.78 $3,127 - $3,651
-265 Reduced 0.77%
34,356 $455,000
Q3 2022

Nov 14, 2022
BUY
$11.61 - $15.22 $4,388 - $5,753
378 Added 1.1%
34,621 $402,000
Q2 2022

Aug 12, 2022
BUY
$14.32 - $19.88 $113,629 - $157,747
7,935 Added 30.16%
34,243 $505,000
Q1 2022

May 13, 2022
SELL
$15.39 - $20.25 $23,531 - $30,962
-1,529 Reduced 5.49%
26,308 $509,000
Q4 2021

Feb 11, 2022
SELL
$15.91 - $18.72 $14,573 - $17,147
-916 Reduced 3.19%
27,837 $480,000
Q3 2021

Nov 12, 2021
SELL
$13.06 - $17.24 $160,651 - $212,069
-12,301 Reduced 29.96%
28,753 $480,000
Q2 2021

Aug 13, 2021
SELL
$11.45 - $13.96 $13,110 - $15,984
-1,145 Reduced 2.71%
41,054 $551,000
Q1 2021

May 07, 2021
SELL
$11.06 - $12.87 $5,231 - $6,087
-473 Reduced 1.11%
42,199 $504,000
Q4 2020

Feb 12, 2021
SELL
$9.33 - $12.48 $9,964 - $13,328
-1,068 Reduced 2.44%
42,672 $529,000
Q3 2020

Nov 04, 2020
SELL
$10.33 - $14.49 $15,071 - $21,140
-1,459 Reduced 3.23%
43,740 $457,000
Q2 2020

Aug 12, 2020
BUY
$11.49 - $15.26 $11,225 - $14,909
977 Added 2.21%
45,199 $632,000
Q1 2020

May 04, 2020
SELL
$8.11 - $15.23 $17,720 - $33,277
-2,185 Reduced 4.71%
44,222 $520,000
Q4 2019

Feb 05, 2020
SELL
$10.28 - $14.38 $13,168 - $18,420
-1,281 Reduced 2.69%
46,407 $657,000
Q3 2019

Nov 08, 2019
SELL
$10.05 - $14.55 $6,612 - $9,573
-658 Reduced 1.36%
47,688 $503,000
Q2 2019

Aug 13, 2019
SELL
$13.1 - $14.95 $47,146 - $53,805
-3,599 Reduced 6.93%
48,346 $704,000
Q1 2019

May 06, 2019
SELL
$13.69 - $20.06 $19,316 - $28,304
-1,411 Reduced 2.64%
51,945 $729,000
Q4 2018

Feb 13, 2019
SELL
$13.96 - $18.26 $9,283 - $12,142
-665 Reduced 1.23%
53,356 $931,000
Q3 2018

Nov 09, 2018
BUY
$13.63 - $15.7 $12,267 - $14,130
900 Added 1.69%
54,021 $823,000
Q2 2018

Aug 08, 2018
BUY
$13.44 - $17.59 $69,686 - $91,204
5,185 Added 10.82%
53,121 $733,000
Q1 2018

May 07, 2018
SELL
$13.8 - $16.99 $158,631 - $195,300
-11,495 Reduced 19.34%
47,936 $799,000
Q4 2017

Feb 09, 2018
SELL
$11.73 - $14.75 $5,818 - $7,316
-496 Reduced 0.83%
59,431 $843,000
Q3 2017

Nov 09, 2017
BUY
$12.06 - $14.12 $722,719 - $846,169
59,927
59,927 $846,000

Others Institutions Holding INVA

# of Institutions
229
Shares Held
79.2M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email